Keryx Biopharmaceuticals (KERX) Stock News

USA - Nasdaq - NASDAQ:KERX -

3.36

-0.07 (-2.04%)

Last: 12/12/2018, 8:17:19 PM

3.35

-0.01 (-0.3%)

After Hours: 12/12/2018, 8:17:19 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

KERX Latest News, Press Relases and Analysis

All

Press Releases

7 years ago - By: Benzinga - Mentions: AKBA

Akebia Poised To Become 'Renal Powerhouse' With Keryx Merger, Raymond James Says

7 years ago - By: The Motley Fool

Why Akebia Therapeutics Is Soaring Today

7 years ago - By: Analyst Ratings - Mentions: ROSG IMUC CRIS CDTI

News Image

Wednesday’s Midday Movers: Rosetta Genomics Ltd (ROSG), ImmunoCellular Therapeutics (IMUC), Curis Inc (CRIS), Keryx Biopharma (KERX), CDTi Advanced Materials Inc (CDTI)

7 years ago - By: StockNews.com

News Image

Keryx Biopharmaceuticals, Inc. (KERX): Bullish PT Set

7 years ago - By: StockNews.com

News Image

Keryx Biopharmaceuticals, Inc. (KERX): Earnings News

7 years ago - By: Benzinga - Mentions: XBI CELG CLSN CTIC ...

The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO

7 years ago - By: Akebia Therapeutics, Inc. and Keryx Biopharmaceuticals, Inc. - Mentions: AKBA

Akebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined Company

7 years ago - By: Analyst Ratings

News Image

Keryx Biopharma (KERX) Receives a Hold from Maxim Group

7 years ago - By: Analyst Ratings - Mentions: HSGX KALA

News Image

Analysts Are Bullish on These Healthcare Stocks: Keryx Biopharma (KERX), Histogenics (HSGX)

7 years ago - By: Monteverde & Associates PC

News Image

Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Keryx Biopharmaceuticals, Inc. In The U.S. District Court For The District Of Delaware

7 years ago - By: Lifshitz & Miller Law Firm - Mentions: UWN ANCX GBT SONC ...

News Image

Lifshitz & Miller LLP Announces Investigation of Access National Corporation, Engility Holdings, Inc., Floor & Decor Holdings, Inc., Global Blood Therapeutics, Inc., Intrexon Corporation, Keryx Biopharmaceuticals, Inc., Nevada Gold & Casinos, Inc., and So

7 years ago - By: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Keryx Biopharmaceuticals, Inc. Merger

7 years ago - By: Monteverde & Associates PC

News Image

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Keryx Biopharmaceuticals, Inc. - KERX

7 years ago - By: Analyst Ratings - Mentions: DVAX

News Image

Analysts Offer Insights on Healthcare Companies: Dynavax (NASDAQ: DVAX) and Keryx Biopharma (NASDAQ: KERX)

7 years ago - By: The Motley Fool

Here's Why Keryx Biopharmaceuticals Dropped 19.6% in August

7 years ago - By: Analyst Ratings

News Image

Keryx Biopharma (KERX) Receives a Buy from H.C. Wainwright

7 years ago - By: StockNews.com

News Image

Keryx Biopharmaceuticals, Inc. (KERX): PT Lowered News

7 years ago - By: StockNews.com

News Image

Keryx Biopharmaceuticals, Inc. (KERX): Bullish Rating Reiterated

7 years ago - By: Analyst Ratings - Mentions: GTHX SRPT

News Image

Analysts Offer Insights on Healthcare Companies: Keryx Biopharma (NASDAQ: KERX), G1 Therapeutics Inc (NASDAQ: GTHX) and Sarepta Therapeutics (NASDAQ: SRPT)